Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8895694 Glucagon-Like Peptide-1 derivatives and their pharmaceutical use

Patent 8895694 was granted and assigned to Novo Nordisk on November, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Novo Nordisk
Novo Nordisk
Date Filed
September 5, 2008
Date of Patent
November 25, 2014
Patent Application Number
12676451
Patent Citations Received
‌
US Patent 12090193 Glucagon-like peptide 1 receptor agonists and uses thereof
0
‌
US Patent 11779633 Glucagon-like peptide 1 receptor agonists and uses thereof
‌
US Patent 11833248 Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid
0
‌
US Patent 11891425 Thioamide-modified peptides and uses thereof
0
‌
US Patent 11759503 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11759502 Compositions of GLP-1 peptides and preparation thereof
‌
US Patent 11759501 Compositions of GLP-1 peptides and preparation thereof
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8895694
Patent Primary Examiner
‌
James H Alstrum-Acevedo

Find more entities like US Patent 8895694 Glucagon-Like Peptide-1 derivatives and their pharmaceutical use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.